^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

ADAMTS1 expression

i
Other names: ADAMTS1, ADAM Metallopeptidase With Thrombospondin Type 1 Motif 1, METH1, KIAA1346, C3-C5, A Disintegrin-Like And Metalloprotease (Reprolysin Type) With Thrombospondin Type 1 Motif, 1, A Disintegrin And Metalloproteinase With Thrombospondin Motifs 1, Metalloprotease And Thrombospondin-1, ADAM-TS 1, ADAM-TS1, ADAMTS-1, METH-1, Human Metalloproteinase With Thrombospondin Type 1 Motifs
Entrez ID:
1year
ADAMTS16 drives epithelial-mesenchymal transition and metastasis through a feedback loop upon TGF-β1 activation in lung adenocarcinoma. (PubMed, Cell Death Dis)
Therefore, ADAMTS16 forms a positive feedback loop with the TGF-β1/SOX4 axis to regulate EMT and metastasis, and disruption of this feedback loop inhibits tumor progression. These findings underscore the potential of ADAMTS16 as a prognostic biomarker and therapeutic target in LUAD and offer novel insight into the mechanism of EMT and metastasis.
Journal
|
TGFB1 (Transforming Growth Factor Beta 1) • SOX4 (SRY-Box Transcription Factor 4)
|
ADAMTS1 expression
1year
The oncogenic ADAMTS1-VCAN-EGFR cyclic axis drives anoikis resistance and invasion in renal cell carcinoma. (PubMed, Cell Mol Biol Lett)
Our results collectively uncover a novel cyclic axis involving ADAMTS1-VCAN-EGFR, which significantly contributes to RCC invasion and resistance to anoikis, thus presenting a promising therapeutic target for RCC metastasis.
Journal
|
EGFR (Epidermal growth factor receptor) • ADAMTS1 (ADAM Metallopeptidase With Thrombospondin Type 1 Motif 1) • VCAN (Versican)
|
ADAMTS1 expression
1year
Associations of SEMA7A, SEMA4D, ADAMTS10, and ADAM8 with KRAS, NRAS, BRAF, PIK3CA, and AKT Gene Mutations, Microsatellite Instability Status, and Cytokine Expression in Colorectal Cancer Tissue. (PubMed, Curr Issues Mol Biol)
The SEMA7A and SEMA4D expressions were correlated with the expression of numerous cytokines associated with various immune processes. The potential immunomodulatory functions of these molecules and their suitability as therapeutic targets require further investigation.
Journal • Microsatellite instability
|
KRAS (KRAS proto-oncogene GTPase) • BRAF (B-raf proto-oncogene) • PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) • NRAS (Neuroblastoma RAS viral oncogene homolog) • MSI (Microsatellite instability) • SEMA7A (Semaphorin 7A) • ADAM8 (ADAM Metallopeptidase Domain 8) • SEMA4D (Semaphorin 4D)
|
KRAS mutation • BRAF mutation • NRAS mutation • PIK3CA mutation • ADAMTS1 expression • SEMA7A expression
almost2years
ADAMTS Gene-Derived circRNA Molecules in Non-Small-Cell Lung Cancer: Expression Profiling, Clinical Correlations and Survival Analysis. (PubMed, Int J Mol Sci)
Furthermore, the higher ADAMTS9 expression was linked to prolonged survival, while the overexpression of ADAMTS12 was correlated with a shorter survival. These findings suggest that circRNA molecules may serve as potential diagnostic or prognostic biomarkers for NSCLC, highlighting the importance of considering molecular patterns in distinct cancer subtypes.
Journal
|
CDKN2B (Cyclin Dependent Kinase Inhibitor 2B) • ADAMTS6 (ADAM Metallopeptidase With Thrombospondin Type 1 Motif 6) • ADAMTS12 (ADAM Metallopeptidase With Thrombospondin Type 1 Motif 12)
|
ADAMTS1 expression
almost2years
Cyclic increase in the ADAMTS1-L1CAM-EGFR axis promotes the EMT and cervical lymph node metastasis of oral squamous cell carcinoma. (PubMed, Cell Death Dis)
Most importantly, API treatment significantly prolonged survival rates of xenograft mice with OSCC. In summary, ADAMTS1 may be a useful biomarker for predicting OSCC progression, and API potentially retarded OSCC progression by targeting the ADAMTS1-L1CAM-EGFR signaling pathway.
Journal
|
ADAMTS1 (ADAM Metallopeptidase With Thrombospondin Type 1 Motif 1) • L1CAM (L1 cell adhesion molecule)
|
ADAMTS1 expression
almost2years
Metformin suppresses proliferation and glycolysis of gastric cancer by modulating ADAMTS12. (PubMed, Genes Environ)
Metformin can repress the proliferation and glycolysis of GC cells via ADAMTS12. The results suggest the potential of ADAMTS12 being a target for the metformin therapy of GC.
Journal
|
CDKN2B (Cyclin Dependent Kinase Inhibitor 2B) • ADAMTS12 (ADAM Metallopeptidase With Thrombospondin Type 1 Motif 12)
|
ADAMTS1 expression
|
metformin
2years
ADAMTS12 is a stromal modulator in chronic liver disease. (PubMed, FASEB J)
These phenotypic changes, together with the down-regulation of PAI-1, were offset by TGF-β treatment. The present study thus identifies ADAMTS12 as a modulator of HSC differentiation, and a new player in chronic liver disease.
Journal • Stroma
|
CDKN2B (Cyclin Dependent Kinase Inhibitor 2B) • TGFB1 (Transforming Growth Factor Beta 1) • ADAMTS12 (ADAM Metallopeptidase With Thrombospondin Type 1 Motif 12)
|
ADAMTS1 expression
2years
ADAMTS12 promotes oxaliplatin chemoresistance and angiogenesis in gastric cancer through VEGF upregulation. (PubMed, Cell Signal)
These findings suggest that ADAMTS12 can modulate signaling via the MAPK/VEGF axis in GC cells to enhance tumor cell resistance to oxaliplatin treatment under hypoxic and normoxic conditions. Elevated ADAMTS12 levels can additionally predict vascular abnormalities, worse survival outcomes, and chemoresistance in patients with GC.
Journal
|
VEGFA (Vascular endothelial growth factor A) • CDKN2B (Cyclin Dependent Kinase Inhibitor 2B) • CD31 (Platelet and endothelial cell adhesion molecule 1) • PECAM1 (Platelet And Endothelial Cell Adhesion Molecule 1) • ADAMTS12 (ADAM Metallopeptidase With Thrombospondin Type 1 Motif 12)
|
CD31 expression • VEGFA expression • ADAMTS1 expression
|
oxaliplatin
over2years
Effects of metalloprotease ADAMTS12 on cervical cancer cell phenotype and its potential mechanism. (PubMed, Discov Oncol)
Co-Immunoprecipitation combined with protein mass spectrometry showed that TGF-β signaling pathway-related proteins interacting with ADAMTS12 were screened from HeLa cells with ADAMTS12 overexpression. Therefore, we concluded that ADAMTS12 may affect the mTOR signaling pathway through the interacting with TGF-β1, and then affect the biological function of cervical cancer cells.
Journal
|
EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) • TGFB1 (Transforming Growth Factor Beta 1)
|
ADAMTS1 expression
over2years
Chinese herbal compound SanHuang decoction reverses axitinib resistance in ccRCC through regulating immune cell infiltration by affecting ADAMTS18 expression. (PubMed, Am J Cancer Res)
Pearson correlation analysis of sample data showed that there was a negative correlation between the expression of ADAMTS18 and PD-L1 in tumor tissues. In conclusion, the Chinese herbal compound SanHuang decoction can reverse axitinib resistance in ccRCC cells by regulating immune cell infiltration and affecting ADAMTS18 expression.
Journal • PD(L)-1 Biomarker • IO biomarker • Immune cell
|
PD-L1 (Programmed death ligand 1) • CD8 (cluster of differentiation 8) • PTPRC (Protein Tyrosine Phosphatase Receptor Type C)
|
PD-L1 expression • ADAMTS1 expression
|
Inlyta (axitinib)
over2years
ADAM metallopeptidase with thrombospondin type 1 motif 16 is a potential marker for prognosis in clear cell renal cell carcinoma. (PubMed, Pathol Int)
Such inhibitory effect may be ascribed to the involvement of AKT/mammalian target of rapamycin signaling. Hence, the present study of ADAMTS16 will provide new insight into the underlying biological mechanisms of ccRCC.
Journal
|
ADAMTS1 expression
over2years
Quantitative proteomics identifies tumour matrisome signatures in patients with non-small cell lung cancer. (PubMed, Front Oncol)
These proteins were up-regulated in lung tumour samples, and high PXDN and ADAMTS16 gene expression was associated with shorter survival of lung adenocarcinoma and squamous cell carcinoma patients, respectively. These data chart extensive remodelling of the lung extracellular niche and reveal tumour matrisome signatures in human NSCLC.
Journal
|
ADAMTS1 expression